Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis.

Nature·2026
Same author

Riboflavin metabolism shapes FSP1-driven ferroptosis resistance.

Nature cell biology·2026
Same author

Fat bolsters tumours against ferroptosis.

Nature cell biology·2026
Same author

Lymph node environment drives FSP1 targetability in metastasizing melanoma.

Nature·2025
Same author

Targeting FSP1 triggers ferroptosis in lung cancer.

Nature·2025
Same author

Decoding ferroptosis for cancer therapy.

Nature reviews. Cancer·2025

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

936

Exploiting ferroptosis vulnerabilities in cancer.

Toshitaka Nakamura1, Marcus Conrad2

  • 1Institute of Metabolism and Cell Death, Molecular Targets & Therapeutics Center, Helmholtz Munich, Neuherberg, Germany.

Nature Cell Biology
|June 10, 2024
PubMed
Summary

Ferroptosis, a cell death form, is a promising cancer therapy target. Understanding its mechanisms and modulation is key to developing new treatments for difficult-to-treat cancers.

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

891
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K

Related Experiment Videos

Last Updated: Jun 24, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

936
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

891
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.3K

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Death Mechanisms
  • Cancer Therapeutics

Background:

  • Ferroptosis is a regulated form of cell death driven by lipid peroxidation.
  • Cancer cells, particularly difficult-to-treat types and those in specific microenvironments, exhibit vulnerability to ferroptosis.
  • Targeting ferroptosis presents a novel therapeutic strategy in oncology.

Purpose of the Study:

  • To review recent advancements in the molecular mechanisms of ferroptosis.
  • To highlight tools for modulating ferroptosis sensitivity in cancer cells.
  • To discuss the interplay between ferroptosis and the tumor immune microenvironment.

Main Methods:

  • Literature review of recent scientific publications on ferroptosis.
  • Analysis of molecular pathways regulating ferroptosis.
  • Evaluation of therapeutic strategies targeting ferroptosis.

Main Results:

  • Detailed understanding of ferroptosis's molecular underpinnings has advanced significantly.
  • Various tools exist to modulate ferroptosis sensitivity in cancer cells.
  • Ferroptosis influences communication within the tumor microenvironment, including with immune cells.

Conclusions:

  • Ferroptosis is a viable and emerging target for cancer therapy.
  • Modulating ferroptosis pathways offers new avenues for overcoming treatment resistance.
  • Further research into ferroptosis activation pathways can enhance cancer treatment strategies.